The lung is a major target tissue for oxidative stress, including hyperoxia
used to relieve tissue hypoxia. Unfortunately, severe hyperoxia damages DN
A, inhibits proliferation, and kills cells, resulting in morbidity and mort
ality. Although hyperoxia induces the tumor suppressor p53 and its downstre
am target, the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1) (p21),
their role in pulmonary injury remains unknown. Using p53- and p21-deficie
nt mice we demonstrate that hyperoxia induces p21 in the absence of p53, su
ggesting that previous conclusions that p53 does not modify hyperoxic lung
injury cannot be extrapolated to p21. In fact, mean survival of p21-deficie
nt mice decreased by 40% and was associated with terminal deoxyribonucleoti
dyl transferase-mediated deoxyuridine triphosphate-biotin nick-end labeling
staining of alveolar debris, indicative of DNA fragmentation and cell deat
h. Ultrastructural analyses revealed that alveolar endothelial and type I e
pithelial cells died rapidly by necrosis. Although hyperoxia decreased DNA
replication in p21-wild-type lungs, it had no effect on replication in p21-
deficient lungs. Our findings suggest that p21 protects the lung from oxida
tive stress, in part, by inhibiting DNA replication and thereby allowing ad
ditional time to repair damaged DNA. Our findings have implications for pat
ients suffering from the toxic effects of supplemental oxygen therapies.